JPRN-UMIN000007117已完成2 期
Gunma study - Oxaliplatin-based chemotherapy and Avastin following Irinotecan-based chemotherapy with Erbitux in metastatic colorectal cancer - GARNET TRIA
Gunma University Graduate school of Medicine Department of General surgical science clinical study group0 个研究点目标入组 53 人开始时间: 2012年1月23日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 53
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Synchronous multiple malignancy or metachronous multiple malignancy within 5 years disease-free interval 2) Symptomatic brain metastases 3) Severe myelosuppression 4) Watery diarrhea 5) Severe infectious disease 6) Interstitial lung disease or pulmonary fibrosis 7) Comorbidity or history of severe heart failure 8) Sensory alteration or paresthesia interfering with function 9) Need to drain malignant coelomic fluid 10) Severe comorbidity 11) Paralytic or mechanical bowel obstruction 12) Jaundice 13) Patient taking Atazanavir sulphate 14) Men/women who are unwilling to avoid pregnancy. Women who are pregnant or breastfeeding. Women with a positive pregnancy test 15) History of severe allergy 16) History of allergy for Cetuximab, Bevacizumab, fluoropyrimidine, irinotecan, oxaliplatin and other platinating agent 17) Prior treatment of Cetuximab, Bevacizumab, fluoropyrimidine, irinotecan and oxaliplatin Any other cases who are regarded as inadequate for study enrollment by investigators
研究者
相似试验
已完成
不适用
Pre and post operative chemotherapy with oxaliplatin, 5-Fluorouracil (5 FU)/Leucovorin (LV) versus surgery alone in resectable liver metastases from colorectal origiColon, rectumCancerISRCTN55293778Cancer Research UK (CRUK) (UK)363
已完成
2 期
Treatment using Oxaliplatin and S-1 Adjuvant chemotherapy for Stage III gastric cancer trialGastric cancerJPRN-UMIN000025824Department of Surgery, Kochi Medical School75
已完成
3 期
A randomized phase III study of oxaliplatin based chemotherapy versus combination chemotherapy of TS-1,irinotecan and bevacizumab as first line therapy for unresectable or recurrent colorectal cancerJPRN-UMIN000007834The Tokyo Cooperative Oncology Group450
已完成
1 期
Phase I/II study of the combination of Oxaliplatin and S-1 in patients with advanced/recurrent colorectal cancerunresectable advanced/recurrent colorectal cancerJPRN-C000000443Outpatient Oncology Unit Kyoto University Hospital42
招募中
2 期
eoadjuvant Chemotherapy with Oxaliplatin plus Fluorouracil l-Leucovorin or Oxaliplatin plus Capecitabin and MoAb for resectable colorectal liver metastases(CML) from tokai digestive cancer trials groupResectable Liver Metastases From Colorectal CancerJPRN-UMIN000003796Epidemiological and Clinical Research Information Network45